… of rich experience in the pharmaceutical sector. Announcing his new … more than two decades at Cipla, where he held various leadership … He began his journey with Cipla in 1999 as a Sales … has Proven expertise in major pharmaceutical therapies, both Acute/ …

… as Sun Pharma, Aurobindo Pharma, Dr Reddy's Lab, Cipla, Gland Pharma, Zydus … the generic medicines in the US, supply chain disruptions, drug shortages and … rationalisation in low-margin products.  Aurobindo Pharma and Gland Pharma …

… last week, he excluded pharmaceuticals from the new tariffs, … medicines from India. India provides nearly half of all generic drugs … used in the U.S., helping cut billions from healthcare … healthcare costs in the U.S. Even though some companies like Cipla …

… , and drive up drug prices. America depends … hikes, and even potential drug shortages. Indian companies, operating … market. Sun Pharmaceutical, India’s largest drugmaker, derived 32% … increase. Similarly, Cipla, Biocon, Lupin, Glenmark Pharma, and Zydus …

… The Indian Pharmaceutical Market (IPM) registered a healthy growth of 7 … to market research firm Pharmarack. This performance reflects the … a 9.5% growth. Cipla remained among the top … for gastrointestinal and reproductive health products. Overall, March …

… , the move will incentivise drug companies to relocate their operations … two principal suppliers of generic drugs to the US market, … tariffs would result in drug companies swiftly returning to … 3% and 5%. Sun Pharma and Cipla also experienced declines. Sign …

… agreement aimed at keeping medicines affordable. This shift comes … drugs, saving the country billions in healthcare costs. Indian pharma … Indians importing American medicines. Indian drugmakers warn that tariffs … up US medical bills. While firms like Cipla and …

… promised” tariffs on pharmaceutical drugs will be announced very … 's pharma tariffs: Will medicines get costlier in … an Indian multinational pharmaceutical and biotechnology company headquartered in … 5%. Sun Pharmaceutical Industries, Cipla, and Dr Reddy …

… the heavyweights like Sun Pharma, Lupin, Cipla, and Dr Reddy’s … were dragging the index.  Sun Pharma … is aimed at encouraging drug firms to move back … the Trump administration had exempted pharmaceuticals, energy, chemicals, and …

Indian pharma stocks, including Sun Pharmaceutical Industries, Gland Pharma, Lupin and others traded sharply … said the tariff will incentivize drug companies to move their operations … 41% and 38% respectively. Sun Pharma and Cipla, two of the biggest …